Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000530898 | SCV000654435 | likely benign | Epilepsy, familial adult myoclonic, 5 | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000530898 | SCV000896225 | uncertain significance | Epilepsy, familial adult myoclonic, 5 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584332 | SCV001811708 | uncertain significance | not provided | 2021-12-15 | criteria provided, single submitter | clinical testing | Reported previously in the heterozygous state in an individual with epilepsy and two control individuals (Stogmann et al., 2013); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23518707) |
Center for Genomics, |
RCV000530898 | SCV003919812 | uncertain significance | Epilepsy, familial adult myoclonic, 5 | 2022-09-28 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 0.08% (56/68034) (https://gnomad.broadinstitute.org/variant/1-205064691-C-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:474464). Evolutionary conservation for this variant is unclear; computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |